Elham Askari
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Antifungal resistance and susceptibility 5
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
- Oncology 6
- CAR-T cell therapy research 3
- Co-authors
- Amrita Krishnan (4 shared papers)Raluca Verona (4 shared papers)Jeffery S. Russell (4 shared papers)Suzette Girgis (4 shared papers)Albert Oriol (4 shared papers)Niels W.C.J. van de Donk (4 shared papers)María‐Victoria Mateos (4 shared papers)Jesús G. Berdeja (4 shared papers)
- Journals
- Blood (3 papers)Physical and Engineering Sciences in Medicine (1 paper)American Journal of Tropical Medicine and Hygiene (1 paper)PLoS ONE (1 paper)Circulation Cardiovascular Imaging (1 paper)
- Partner nations
- IranSpainNetherlands
In The Last Decade
Elham Askari
24 papers receiving 689 citations
Elham Askari's Hit Papers
Peers
Comparison fields: 5 of 72
- Hematology 311
- Oncology 308
- Radiology, Nuclear Medicine and Imaging 154
- Immunology 106
- Infectious Diseases 83
Countries citing papers authored by Elham Askari
This map shows the geographic impact of Elham Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Askari more than expected).
Fields of papers citing papers by Elham Askari
This network shows the impact of papers produced by Elham Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Askari. The network helps show where Elham Askari may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Askari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma Hit paper breakdown → | 2022 | 392 |
| 2 | 2020 | 48 | |
| 3 | 2021 | 40 | |
| 4 | 2021 | 37 | |
| 5 | 2014 | 33 | |
| 6 | 2020 | 31 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 20 | |
| 9 | 2011 | 10 | |
| 10 | 2023 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 7 | |
| 16 | 2022 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2022 | 1 |
About Elham Askari
Elham Askari is a scholar working on Infectious Diseases, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 26 papers that have together received 702 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (5 papers), Multiple Myeloma Research and Treatments (5 papers), COVID-19 Clinical Research Studies (5 papers), Fungal Infections and Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Hematology (311 citations), Oncology (308 citations), Radiology, Nuclear Medicine and Imaging (154 citations), Immunology (106 citations) and Infectious Diseases (83 citations). Elham Askari has collaborated with scholars based in Iran, Spain and Netherlands. Frequent co-authors include Amrita Krishnan, Raluca Verona, Jeffery S. Russell, Suzette Girgis, Albert Oriol, Niels W.C.J. van de Donk, María‐Victoria Mateos, Jesús G. Berdeja, Monique C. Minnema and Brandi Hilder. Their work appears in journals such as Blood, Physical and Engineering Sciences in Medicine, American Journal of Tropical Medicine and Hygiene, PLoS ONE and Circulation Cardiovascular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.